Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

The Trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the "Portfolio"), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index.

Accounts payable

Total current assets

Cash

Short/Current long term debt

Goodwill

Intangible assets

Net tangible assets

Property, plant and equipment

Net receivables

Shareholder's equity

Total assets

Total current liabilities

Total liabilities

Balance Sheet

Capital expenditures (TTM)

Operating cash flow (TTM)

Dividends paid (TTM)

Free cash flow (TTM)

Cash flow

DGR 10 years

DGR 15 years

DGR 3 years

DGR 5 years

DGR MR

DGR TTM

EPS growth (5y forward)

EPS growth (5y)

Time since last change announced

Dividend growth

Average yield

Yield as % of max yield

Discount to avg yield

Dividend per share

Dividend yield

Payout frequency

Maximum yield

Minimum yield

Upside potential

Dividend yield - 5y

Avg time to new high

Avg drop from high

Max time to new high

Highest price drop

Date of highest drop

Current price drop from All-time high

Downside potential

CCC status

Years of growth

EPS (1y forward)

EPS (TTM)

Ex-div date

Cash Return on Invested Capital

Return on Assets

Return on Equity

Return on Invested Capital

Financial returns

Gross profit (TTM)

Net income (TTM)

Operating income (TTM)

Revenue (TTM)

Income statement

Gross margin (TTM)

Operating margin (TTM)

Profit margin (TTM)

Margins

Average

Forward

Payout ratio

FCF per share (TTM)

Current share count

Per share

Current yield distribution

Yield at 0% (Max)

Yield at 10%

Yield at 100% (Min)

Yield at 20%

Yield at 50% (Median)

Yield at 80%

Yield at 90%

Yield distribution (inverse percentile) - 5y

All-time high

1y analyst estimate

Beta

Price at close

Daily high

Daily low

Open

Daily Volume

Next earnings date

Stock chart

EV to Sales

Price to Book

Price to Sales

Valuation (Sales/Book Value)

EV to EBITDA

Trailing P/E

Price to EBITDA

Price to FCF

Price to OCF

Valuation Ratios

	MACK	S&P500
Current price drop from All-time high	-85.93%	-0.06%
Highest price drop	-98.48%	-56.47%
Date of highest drop	20 Mar 2020	9 Mar 2009
Avg drop from high	-71.19%	-11.07%
Avg time to new high	113 days	12 days
Max time to new high	2284 days	1805 days

Ticker
MACK

DIVIDENDS

VALUATION

Valuation Ratios

Valuation (Sales/Book Value)

FINANCIALS

Per share

Income statement

Margins

Balance Sheet

Cash flow

Financial returns

STOCK INFORMATION

Downside potential

Revenue (TTM)	0.00
Gross profit (TTM)	0.00
Operating income (TTM)	-2.26M
Net income (TTM)	-24.54M

Cash	234.16M
Net receivables	0.00
Total current assets	244.32M
Goodwill	0.00
Intangible assets	0.00
Property, plant and equipment	0.00
Total assets	244.32M
Accounts payable	168.00K
Short/Current long term debt	0.00
Total current liabilities	22.67M
Total liabilities	22.67M
Shareholder's equity	221.65M
Net tangible assets	0.00

Operating cash flow (TTM)	-2.48M
Capital expenditures (TTM)	0.00
Free cash flow (TTM)	-2.48M
Dividends paid (TTM)	0.00

TickerMACK

DIVIDENDS

VALUATION

Valuation Ratios

Valuation (Sales/Book Value)

FINANCIALS

Per share

Income statement

Margins

Balance Sheet

Cash flow

Financial returns

STOCK INFORMATION

Downside potential

Ticker
MACK